James Ellingford
Follow
Get notifications in MyBN when activity occurs.
James Ellingford
Dr James Ellingford has experience in the international arena and has successfully developed close ties with financial institutions and governments throughout the world.
Dr Ellingford holds a Post Graduate in Corporate Management, a Masters in Business Administration, and a Doctorate in Management.
Previously, he has chaired boards including MinRex Resources, Creso Pharma and Zyber Holdings (see data below).
Dr Ellingford holds a Post Graduate in Corporate Management, a Masters in Business Administration, and a Doctorate in Management.
Previously, he has chaired boards including MinRex Resources, Creso Pharma and Zyber Holdings (see data below).
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| th | Pioneer Lithium | ||
| 458th | Predictive Discovery | 15% | 80% |
| 726th | Javelin Minerals | 0% | 0% |
| 1459th | Peregrine Gold | -50% | |
| 1663rd | Prospect Resources | -64% | 19% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 494th |  | Javelin Minerals | $0 |
| 533rd | | Peregrine Gold | $0 |
| 535th |  | Pioneer Lithium | $0 |
| 537th | | Predictive Discovery | $0 |
| 538th | | Prospect Resources | $0 |
604 listed resources wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Creso chair steps back following ASIC notice | 25 Nov 2021 |
| REMUNERATION UPDATE: Executive Director, Interim Chair since 2021, Creso Pharma | 03 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, MinRex Resources | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, MinRex Resources | 30 Jun 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Executive Director, Interim Chair since 2021 | | 2015 - 2022 | 33 |
| Non-Executive Director | | 2020 - 2022 | 174 |
| Non-Executive Chair | | 2017 - 2020 | 377 |
| Non-Executive Chair | | 2011 - 2019 | 494 |
| Non-Executive Director | | 2017 - 2018 | 530 |
| Non-Executive Chair | | 2014 - 2016 | |
| Non-Executive Chairman | | 2014 - 2016 | |
| Non-Executive Director | | 2013 - 2015 | |
| Non-Executive Director | | - | |
| Non-Executive Director | | - | 259 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Creso Pharma | 02 Nov 2021 | Issued | 384,167 | OtherIssue of options: As per announcement on 08/11/2021 | ||
| Creso Pharma | 14 Jul 2021 | Issued | 500,000 | OtherIssue of securities | ||
| Creso Pharma | 09 Mar 2021 | Other | 797,500 | OtherOff-market transfer | ||
| Javelin Minerals | 30 Nov 2018 | Other | 33,333 | OtherOptions expired | ||
| Creso Pharma | 21 Aug 2018 | Issued | 550,000 | $0.05 | $27,500 | Rights issue |
Powered by Morningstar ®
Equity Capital Markets Deals
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| 27/09/12 | Javelin Minerals | Initial public offering | $4.0m | >> |
Mergers & Acquisitions Deals
| Announced | Bidder | Target | Transaction Type | Total Value | |
|---|---|---|---|---|---|
| 02/09/15 | Dourado Resources | Zyber Holdings | Reverse takeover | $2.6m | >> |
